Neogenomics (NEO) Debt to Equity (2009 - 2025)
Neogenomics (NEO) debt to equity from Dec 31, 2009 to Dec 31, 2025. The current Neogenomics (NEO) debt to equity is 40.86%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Neogenomics (NEO)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 40.86% | -31.85% |
| 2024 | 59.97% | +4.91% |
| 2023 | 57.16% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | 0.99% | -96.87% |
| 2018 | 31.44% | -43.02% |
| 2017 | 55.18% | -6.41% |
| 2016 | 58.96% | +132.84% |
| 2015 | 25.32% | N/A |
| 2014 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2010 | 0.00% | N/A |
| 2009 | 0.00% | N/A |
Comparison Neogenomics (NEO) debt to equity with competitors
Neogenomics (NEO) debt to equity is 40.86%.